Dr. Siegmar Pohl, with over two decades of experience, focuses his practice on cross-border M&A and complex intellectual property (IP) transactions. He frequently represents clients regarding strategic investments and corporate venture capital, including when paired with research and development (R&D) collaborations or joint ventures. Siegmar has a lot of experience in working with companies from Europe, Asia, and the United States.
Frequently, his clients ask Siegmar to advise them on minimizing their liability risks when launching technology products and when entering the U.S. market. Siegmar regularly holds workshops and training sessions for board members and managers, coaching them on their duties, liabilities, and corporate governance issues. He is also a frequent speaker at international conferences and workshops.
Prior to joining the firm, Siegmar was a partner in the San Francisco, California office of an international law firm. Previously, he worked as an associate with the same firm.
Siegmar is fluent in German.
Represented TTTech Industrial (Vienna, Austria) in an asset acquisition from Nebbiolo Technologies, Inc., a Silicon Valley technology company in the field of fog computing for automotive and other applications.
Represented Mercedes-Benz USA (MBUSA) in the development of fleet service and data license agreements for automotive customers and vehicle operators, including location and maintenance data as well as complex multi-party contractual relationships.
Representing the joint venture between a California start-up and a South Korean pharmaceutical company focusing on the development and commercialization of cancer drugs.
Represented Westbridge Agricultural Products, Inc., an organic pesticide and fertilizer company from San Diego, California, in a $35 million merger with a U.S. subsidiary, Bio-Ferm, of the Erber Group from Vienna, Austria.
Represented California-based biotechnology pioneer for life science tools presenting genomic characteristics in complex intellectual property agreements with a large Korean manufacturer and involving licenses from the University of California.
Advised Targos Molecular Pathology GmbH, a leader in clinical biomarker services from Kassel, Germany, in connection with its joint venture with AKESOgen Inc., Norcross, Georgia.
Represented the largest organization for applied research and development services in Europe with regard to its strategic investment in a U.S. spin-out developing and commercializing ball tracking technologies in sport stadiums.
Represented Austria-based technology leader in networked safety controls, safe software and hardware platforms supporting automated driving regarding its strategic investment in a Silicon Valley fog computing company.
Represented one of the world's leading suppliers of robotics as well as plant manufacturing and system technology in connection with its strategic investment in a Silicon Valley technology company.
*Represented Tan Chong International in negotiations of a manufacturing joint venture with Nissan, including construction, ownership and management of manufacturing facilities and operations.
*Represented the German manufacturer of music production software and hardware in the acquisition of a U.S. content library specialized in recording top musicians.
*Represented the French acquirer of a leading manufacturer of bottle caps for still and sparkling wines in California.
*Represented San Francisco-based innovative industry leader in wireless network development throughout the Western U.S. in a complex private equity transaction.
*Advised leading German manufacturer of household appliances on minimization of legal risks in connection with the launch of a new consumer product on the U.S. market.
*Acted as U.S. counsel to a leading multinational manufacturer of solar technology equipment with group companies and operations in the U.S. in the negotiation and closing of a €100 million syndicated revolving credit facility.
*Represented a leading German robotics technology company in its investment cooperation in innovative Silicon Valley cloud computing company.
*Represented a Chinese acquirer in the divestiture of sensor chips development and manufacturing assets in several European countries and U.S. states.
*Represented a California-based oil company in the due diligence, bidding process, and negotiation of a $44 million stock sale and purchase agreement, the first sale in the company’s history.
*Represented a well-known international tobacco company – with products sold in 120 countries – in an acquisition, joint venture and marketing agreement totaling $74.5 million with a San Francisco manufacturer of inhaling technology.
*Represented a Silicon Valley online social network in corporate, commercial, and international IP law, as well as in venture capital financings.
*Represented a large manufacturer of software and hardware for computer-based audio production in the $50 million sale of a leading music-download site; ongoing advice on strategic acquisitions.
*Experience gained by attorney prior to joining Kilpatrick Townsend
Insights View All
Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn, Germany Ph.D. (2001) Law, magna cum laude
University of Iowa College of Law LL.M. (1996)
Universität Trier, Trier, Germany J.D. (1994) Law and Politics
University of East Anglia, Norwich, United Kingdom Certificate in English Law (1991)
German American Business Association of California (GABA), Board of Directors, Member
German School of the East Bay, Inc., Board of Directors, President
Licensing; Executives of America (LES), Member
German American Chamber of Commerce, Member
German Accelerator Tech, Silicon Valley, Mentor
While we are pleased to have you contact us by telephone, surface mail, electronic mail, or by facsimile transmission, contacting Kilpatrick Townsend & Stockton LLP or any of its attorneys does not create an attorney-client relationship. The formation of an attorney-client relationship requires consideration of multiple factors, including possible conflicts of interest. An attorney-client relationship is formed only when both you and the Firm have agreed to proceed with a defined engagement.
DO NOT CONVEY TO US ANY INFORMATION YOU REGARD AS CONFIDENTIAL UNTIL A FORMAL CLIENT-ATTORNEY RELATIONSHIP HAS BEEN ESTABLISHED.
If you do convey information, you recognize that we may review and disclose the information, and you agree that even if you regard the information as highly confidential and even if it is transmitted in a good faith effort to retain us, such a review does not preclude us from representing another client directly adverse to you, even in a matter where that information could be used against you.